Glycochenodeoxycholic Acid-[D9]

STABLE ISOTOPES

CAT No.# CS-I-00084
Category Stable Isotopes
CAS 640-79-9
Stock Status
AVAILABLE ENQUIRE NOW View COA

(Available within 3-5 days)

Product maybe under re-certification or re-stock. Enquire now to know exact date of delivery and pricing.
Molecular Weight 458.6788
Molecular Formula C26H34D9NO5
Purity: >98%
Synonyms: 2-[(4R)-4-[(1S,2S,5R,9R,11S,14R,15R)-5,9-dihydroxy-2,15-dimethyl(4,4,5,6,6,8,8,9,10-2H9)tetracyclo[8.7.0.02,7.011,15]heptadecan-14-yl]pentanamido]acetic acid
Shipping: Free Shipping for worldwide on order above 2000 USD
Glycochenodeoxycholic Acid-[D9] Worldwide Suppliers of Glycochenodeoxycholic Acid-[D9] Stable Isotopes Clearsynth CS-I-00084

Product rating: 9 Glycochenodeoxycholic Acid-[D9] based on 20 ratings

  1. Stable Isotopes
  2. Glycochenodeoxycholic Acid-[D9]


PEOPLE ALSO SEARCHED FOR: 1. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
2. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
3. Lauroside D
4. Triazolam 13C D3
5. Icatibant impurity 1
6. BISPHENOL AF (RING-13C12)
7. 0.1% TFA in Water ULC-MS
8. Metamizole EP Impurity C HCl
9. Silodosin Metabolite D4
10. Silodosin Metabolite
11. 2-Phenoxymethanesulfonanilide
12. Nimesulide EP Impurity A
13. Acetone HPLC
14. Riluzole (1604337)
15. Pheniramine impurity B
16. Palbociclib N-Glucuronide
17. Carpropamid
18. Olmesartan N1-Trityl Impurity
19. 1-Octadecanethiol
20. H-Ser(Bzl)-OBzl . p-tosylate (E-3755.0005)
Smileys:
C[C@@]1([C@@]2([H])[C@H](C)CCC(NCC(O)=O)=O)[C@](CC2)([H])[C@@]([C@](C([2H])([2H])[C@]3([H])C([2H])([2H])[C@](O)([2H])C([2H])([2H])C4)([2H])O)([2H])[C@]([C@]34C)([H])CC1



This page contains information about Glycochenodeoxycholic Acid-[D9] Cas 640-79-9 and its Stable Isotopes.

Glycochenodeoxycholic Acid-[D9] Glycochenodeoxycholic Acid-[D9] Worldwide Suppliers of Glycochenodeoxycholic Acid-[D9] Stable Isotopes Clearsynth 640-79-9

"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."